Loading data
COGTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 269.78 m USD | 232.66 m USD | 173.76 m USD | 121.63 m USD | 55.91 m USD |
| Operating profit | -333.36 m USD | -275.94 m USD | -208.13 m USD | -147.84 m USD | -75.55 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -328.94 m USD | -255.86 m USD | -192.41 m USD | -140.24 m USD | -72.27 m USD |
| Net income attributable to common shareholders | — | — | -192.41 m USD | -140.24 m USD | -72.27 m USD |
| Basic earnings per share | -2.16 USD/share | -1.94 USD/share | -1.94 USD/share | -1.73 USD/share | -1.87 USD/share |
| Diluted earnings per share | -2.16 USD/share | -1.94 USD/share | -1.94 USD/share | -1.73 USD/share | -1.87 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.